Occult HBV reactivation induced by ibrutinib treatment: a case report
- PMID: 26712054
Occult HBV reactivation induced by ibrutinib treatment: a case report
Abstract
Ibrutinib is a small molecule that has been recently developped for the treatment of B cell malignancies. Common side effects are diarrhoea, nausea, fatigue, infections, neutropenia and thrombocytopenia. Here we report the first case of Hepatitis B virus reactivation in a 80 years old chronic lymphocytic leukaemia patient receiving ibrutinib, suggesting that such treatment must be associated with HBV screening.
© Acta Gastro-Enterologica Belgica.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
